Azithromycin differentially alters tcr-activated helper t cell subset phenotype and effector function

HIGHLIGHTS

• who: Qutayba Hamid and Rifat Akram Hamoudi from the Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates, Department of Pulmonary Montreal, QC, Canada have published the article: Azithromycin Differentially Alters TCR-Activated Helper T Cell Subset Phenotype and Effector Function, in the Journal: (JOURNAL)
• what: The authors report the cellular basis of phenotypic and functional changes associated with AZM treatment of various Th subsets. Using well-characterized Th1 and Th2 subset specific chemokine receptor CXCR3 and CCR4, the authors show Frontiers in Immunology | www.frontiersin.org September 2020 | Volume 11 | Article . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.